The DOI matches its Crossref record; 63 of the 63 references it cites were found in a registry or an index.
Homozygous ablation of fibroblast growth factor-23 results in hyperphosphatemia and impaired skeletogenesis, and reverses hypophosphatemia in Phex-deficient mice
Open accessOverview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Developmental regulation of the growth plate
Kronenberg, H. M. (2003) · Nature · doi:10.1038/nature01657 · Cited by 2,849
Block, G., Hulbert-Shearon, T., Levin, N., & Port, F. (1998) · American Journal of Kidney Diseases · doi:10.1053/ajkd.1998.v31.pm9531176 · Cited by 2,354
The Dialysis Encephalopathy Syndrome: Possible Aluminum Intoxication
Alfrey, A. C., LeGendre, G. R., & Kaehny, W. D. (1976) · New England Journal of Medicine · doi:10.1056/nejm197601222940402 · Cited by 1,621
Shimada, T., Kakitani, M., Yamazaki, Y., Hasegawa, H., Takeuchi, Y., Fujita, T., Fukumoto, S., Tomizuka, K., & Yamashita, T. (2004) · Journal of Clinical Investigation · doi:10.1172/jci19081 · Cited by 1,596
Autosomal dominant hypophosphataemic rickets is associated with mutations in FGF23
White, K. E., Evans, W. E., O'Riordan, J. L. H., Speer, M. C., Econs, M. J., Lorenz-Depiereux, B., Grabowski, M., Meitinger, T., & Strom, T. M. (2000) · Nature Genetics · doi:10.1038/81664 · Cited by 1,528
Cloning and characterization of FGF23 as a causative factor of tumor-induced osteomalacia
Shimada, T., Mizutani, S., Muto, T., Yoneya, T., Hino, R., Takeda, S., Takeuchi, Y., Fujita, T., Fukumoto, S., & Yamashita, T. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.101545198 · Cited by 1,457
GANESH, S. K., STACK, A. G., LEVIN, N. W., HULBERT-SHEARON, T., & PORT, F. K. (2001) · Journal of the American Society of Nephrology · doi:10.1681/asn.v12102131 · Cited by 1,204
Lethal skeletal dysplasia from targeted disruption of the parathyroid hormone-related peptide gene.
Karaplis, A. C., Luz, A., Glowacki, J., Bronson, R. T., Tybulewicz, V. L., Kronenberg, H. M., & Mulligan, R. C. (1994) · Genes & Development · doi:10.1101/gad.8.3.277 · Cited by 1,153
Francis, F., Hennig, S., Korn, B., Reinhardt, R., de Jong, P., Poustka, A., Lehrach, H., Rowe, P. S. N., Goulding, J. N., Summerfield, T., et al. (1995) · Nature Genetics · doi:10.1038/ng1095-130 · Cited by 1,107
Teratocarcinomas and Embryonic Stem Cells: A Practical Approach
Robertson, E. J., & Beddington, R. (1988) · Development · doi:10.1242/dev.102.1.3 · Cited by 1,030
Fibroblast Growth Factor 23 in Oncogenic Osteomalacia and X-Linked Hypophosphatemia
Jonsson, K. B., Zahradnik, R., Larsson, T., White, K. E., Sugimoto, T., Imanishi, Y., Yamamoto, T., Hampson, G., Koshiyama, H., Ljunggren, Ö., et al. (2003) · New England Journal of Medicine · doi:10.1056/nejmoa020881 · Cited by 914
Teratocarcinomas and embryonic stem cells: A practical approach
Krumlauf, R. (1987) · Trends in Genetics · doi:10.1016/0168-9525(87)90286-1 · Cited by 764
Larsson, T., Nisbeth, U. L. F., Ljunggren, Ö., Jüppner, H., & Jonsson, K. B. (2003) · Kidney International · doi:10.1046/j.1523-1755.2003.00328.x · Cited by 689
Georges, G. T., Nájera, O., Sowers, K., & Sowers, J. R. (2017) · Cardiorenal Medicine · doi:10.1159/000449476 · Cited by 680
Yamazaki, Y., Okazaki, R., Shibata, M., Hasegawa, Y., Satoh, K., Tajima, T., Takeuchi, Y., Fujita, T., Nakahara, K., Yamashita, T., et al. (2002) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2002-021105 · Cited by 671
FGF-23 in fibrous dysplasia of bone and its relationship to renal phosphate wasting
Riminucci, M., Collins, M. T., Fedarko, N. S., Cherman, N., Corsi, A., White, K. E., Waguespack, S., Gupta, A., Hannon, T., Econs, M. J., et al. (2003) · Journal of Clinical Investigation · doi:10.1172/jci18399 · Cited by 657
Differential staining of cartilage and bone in whole mouse fetuses by alcian blue and alizarin red S
McLeod, M. J. (1980) · Teratology · doi:10.1002/tera.1420220306 · Cited by 613
Block, G. A., & Port, F. K. (2000) · American Journal of Kidney Diseases · doi:10.1016/s0272-6386(00)70064-3 · Cited by 594
(2002) · Elsevier eBooks · doi:10.1016/b978-0-12-098652-1.x5100-2 · Cited by 591
Yamashita, T., Yoshioka, M., & Itoh, N. (2000) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.2000.3696 · Cited by 554
Regulation of Fibroblastic Growth Factor 23 Expression but Not Degradation by PHEX
Liu, S., Guo, R., Simpson, L. G., Xiao, Z.-S., Burnham, C. E., & Quarles, L. D. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m304544200 · Cited by 508
Larsson, T., Marsell, R., Schipani, E., Ohlsson, C., Ljunggren, Ö., Tenenhouse, H. S., Jüppner, H., & Jonsson, K. B. (2004) · Endocrinology · doi:10.1210/en.2003-1768 · Cited by 499
Brown, W. A. B. (1985) · FEBS Letters · doi:10.1016/0014-5793(85)81367-3 · Cited by 495
Shimada, T. (2002) · Endocrinology · doi:10.1210/en.143.8.3179 · Cited by 446
Shimada, T., Urakawa, I., Yamazaki, Y., Hasegawa, H., Hino, R., Yoneya, T., Takeuchi, Y., Fujita, T., Fukumoto, S., & Yamashita, T. (2004) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2003.12.102 · Cited by 429
Saito, H., Kusano, K., Kinosaki, M., Ito, H., Hirata, M., Segawa, H., Miyamoto, K.-I., & Fukushima, N. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m207872200 · Cited by 414
Calcium Carbonate as a Phosphate Binder in Patients with Chronic Renal Failure Undergoing Dialysis
Slatopolsky, E., Weerts, C., Lopez-Hilker, S., Norwood, K., Zink, M., Windus, D., & Delmez, J. (1986) · New England Journal of Medicine · doi:10.1056/nejm198607173150304 · Cited by 379
Serum FGF23 Levels in Normal and Disordered Phosphorus Homeostasis
Weber, T. J., Liu, S., Indridason, O. S., & Quarles, L. D. (2003) · Journal of Bone and Mineral Research · doi:10.1359/jbmr.2003.18.7.1227 · Cited by 354
Ott, S. M., Maloney, N. A., Coburn, J. W., Alfrey, A. C., & Sherrard, D. J. (1982) · New England Journal of Medicine · doi:10.1056/nejm198209163071202 · Cited by 353
FGF-23 Inhibits Renal Tubular Phosphate Transport and Is a PHEX Substrate
Bowe, A. E., Finnegan, R., Jan de Beur, S. M., Cho, J., Levine, M. A., Kumar, R., & Schiavi, S. C. (2001) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.2001.5084 · Cited by 344
FGF23, PHEX, and MEPE regulation of phosphate homeostasis and skeletal mineralization
Quarles, L. D. (2003) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00016.2003 · Cited by 333
Bai, X., Miao, D., Li, J., Goltzman, D., & Karaplis, A. C. (2004) · Endocrinology · doi:10.1210/en.2004-0233 · Cited by 329
White, K. E. (2001) · Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.86.2.497 · Cited by 329
Slatopolsky, E. A., Burke, S. K., & Dillon, M. A. (1999) · Kidney International · doi:10.1046/j.1523-1755.1999.00240.x · Cited by 302
Secreted frizzled-related protein 4 is a potent tumor-derived phosphaturic agent
Berndt, T., Craig, T. A., Bowe, A. E., Vassiliadis, J., Reczek, D., Finnegan, R., Jan De Beur, S. M., Schiavi, S. C., & Kumar, R. (2003) · Journal of Clinical Investigation · doi:10.1172/jci18563 · Cited by 293
Bai, X.-Y., Miao, D., Goltzman, D., & Karaplis, A. C. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m210490200 · Cited by 276
FGF-23 in patients with end-stage renal disease on hemodialysis
Imanishi, Y., Inaba, M., Nakatsuka, K., Nagasue, K., Okuno, S., Yoshihara, A., Miura, M., Miyauchi, A., Kobayashi, K., Miki, T., et al. (2004) · Kidney International · doi:10.1111/j.1523-1755.2004.00604.x · Cited by 272
MEPE has the properties of an osteoblastic phosphatonin and minhibin
Rowe, P. S. N., Kumagai, Y., Gutierrez, G., Garrett, I. R., Blacher, R., Rosen, D., Cundy, J., Navvab, S., Chen, D., Drezner, M. K., et al. (2004) · Bone · doi:10.1016/j.bone.2003.10.005 · Cited by 268
The phosphatonin pathway: New insights in phosphate homeostasis
Schiavi, S. C., & Kumar, R. (2004) · Kidney International · doi:10.1111/j.1523-1755.2004.00355.x · Cited by 251
Chertow, G. M., Burke, S. K., Lazarus, J. M., Stenzel, K. H., Wombolt, D. G., Goldberg, D., Bonventre, J. V., & Slatopolsky, E. (1997) · American Journal of Kidney Diseases · doi:10.1016/s0272-6386(97)90009-3 · Cited by 244
Octreotide Therapy for Tumor-Induced Osteomalacia
Seufert, J., Ebert, K., Müller, J., Eulert, J., Hendrich, C., Werner, E., Schütze, N., Schulz, G., Kenn, W., Richtmann, H., et al. (2001) · New England Journal of Medicine · doi:10.1056/nejmoa010839 · Cited by 234
Tumors Associated With Oncogenic Osteomalacia Express Genes Important in Bone and Mineral Metabolism
De Beur, S. M. J., Finnegan, R. B., Vassiliadis, J., Cook, B., Barberio, D., Estes, S., Manavalan, P., Petroziello, J., Madden, S. L., Cho, J. Y., et al. (2002) · Journal of Bone and Mineral Research · doi:10.1359/jbmr.2002.17.6.1102 · Cited by 212
Pex Gene Deletions in Gy and Hyp Mice Provide Mouse Models for X-Linked Hypophosphatemia
Strom, T. M., Francis, F., Lorenz, B., Boddrich, A., Lehrach, H., Econs, M. J., & Meitinger, T. (1997) · Human Molecular Genetics · doi:10.1093/hmg/6.2.165 · Cited by 199
Cardiovascular disease in end-stage renal disease patients
Collins, A. J., Li, S., Ma, J. Z., & Herzog, C. (2001) · American Journal of Kidney Diseases · doi:10.1053/ajkd.2001.27392 · Cited by 186
Production and analysis of chimeric mice
Bradley, A. (1987) · Cited by 179
Du, L., Desbarats, M., Viel, J., Glorieux, F. H., Cawthorn, C., & Ecarot, B. (1996) · Genomics · doi:10.1006/geno.1996.0421 · Cited by 174
Miao, D., Bai, X., Panda, D., McKee, M. D., Karaplis, A. C., & Goltzman, D. (2001) · Endocrinology · doi:10.1210/endo.142.2.7976 · Cited by 162
Mutational analysis of the PEX gene in patients with X-linked hypophosphatemic rickets.
Holm, I. A., Huang, X., & Kunkel, L. M. (1997) · PubMed · Cited by 155
Argiro, L., Desbarats, M., Glorieux, F. H., & Ecarot, B. (2001) · Genomics · doi:10.1006/geno.2001.6553 · Cited by 153
Tenenhouse, H. S. (1999) · Nephrology Dialysis Transplantation · doi:10.1093/ndt/14.2.333 · Cited by 143
Oncogenic Osteomalacia — A Complex Dance of Factors
Carpenter, T. O. (2003) · New England Journal of Medicine · doi:10.1056/nejme030037 · Cited by 125
Autosomal dominant hypophosphatemic rickets is linked to chromosome 12p13.
Econs, M. J., McEnery, P. T., Lennon, F., & Speer, M. C. (1997) · Journal of Clinical Investigation · doi:10.1172/jci119809 · Cited by 121
Intrinsic mineralization defect inHyp mouse osteoblasts
Xiao, Z., Crenshaw, M. A., Guo, R., Nesbitt, T., Drezner, M. K., & Quarles, L. D. (1998) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.1998.275.4.e700 · Cited by 114
Lanske, B., Pajevic, P. D., Kovács, C. S., Pirro, A. E., Landis, W. J., Krane, S. M., Bringhurst, F. R., & Kronenberg, H. M. (1998) · Endocrinology · doi:10.1210/endo.139.12.6361 · Cited by 103
Self-citationBai, X., Miao, D., Panda, D., Grady, S., McKee, M. D., Goltzman, D., & Karaplis, A. C. (2002) · Molecular Endocrinology · doi:10.1210/me.2002-0113 · Cited by 100
Campos, M., COUTURE, C., Hirata, I. Y., Juliano, M. A., Loisel, T. P., Crine, P., Juliano, L., Boileau, G., & Carmona, A. K. (2003) · Biochemical Journal · doi:10.1042/bj20030287 · Cited by 98
Fibroblast Growth Factor 23: A New Clinical Marker for Oncogenic Osteomalacia
Nelson, A. E., Clifton-Bligh, R. J., Mirams, M., Gill, A. J., Au, A. Y. M., Clarkson, A., Jüppner, H., Ruff, S. J., Stalley, P., Scolyer, R. A., et al. (2003) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2002-021919 · Cited by 95
FGF23, hypophosphatemia, and rickets: Has phosphatonin been found?
Strewler, G. J. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.111154898 · Cited by 75
Etiology of Hypercalcemia in Hemodialysis Patients on Calcium Carbonate Therapy
Meric, F., Yap, P., & BIA, M. J. (1990) · American Journal of Kidney Diseases · doi:10.1016/s0272-6386(12)80059-x · Cited by 61
Gagnon, L. H., Bauschatz, J. D., Davisson, M. T., Washburn, L. L., Donahue, L. R., Strom, T. M., Eicher, E. M., Johnson, K. R., Guido, V., Lorenz‐Depiereux, B., et al. (2004) · Mammalian Genome · doi:10.1007/s00335-003-2310-z · Cited by 59
Phosphorus Homeostasis and Related Disorders
Drezner, M. K. (2008) · Elsevier eBooks · doi:10.1016/b978-0-12-373884-4.00042-2 · Cited by 30
Lanske, B. (1998) · Endocrinology · doi:10.1210/en.139.12.5194 · Cited by 19
Self-citationFibroblast Growth Factor 23: A Phosphatonin Regulating Phosphate Homeostasis?
Dunstan, C. R., Zhou, H., & Seibel, M. J. (2004) · Endocrinology · doi:10.1210/en.2004-0354 · Cited by 18
Cited by
The Fibroblast Growth Factor signaling pathway
Ornitz, D. M., & Itoh, N. (2015) · WIREs Developmental Biology · doi:10.1002/wdev.176 · Cited by 2,050
The FGF family: biology, pathophysiology and therapy
Beenken, A., & Mohammadi, M. (2009) · Nature Reviews Drug Discovery · doi:10.1038/nrd2792 · Cited by 1,945
Klotho converts canonical FGF receptor into a specific receptor for FGF23
Urakawa, I., Yamazaki, Y., Shimada, T., Iijima, K., Hasegawa, H., Okawa, K., Fujita, T., Fukumoto, S., & Yamashita, T. (2006) · Nature · doi:10.1038/nature05315 · Cited by 1,850
Gutierrez, O., Isakova, T., Rhee, E., Shah, A., Holmes, J., Collerone, G., Ju[Combining Diaeresis]ppner, H., & Wolf, M. (2005) · Journal of the American Society of Nephrology · doi:10.1681/asn.2005010052 · Cited by 921
Dhingra, R. (2007) · Archives of Internal Medicine · doi:10.1001/archinte.167.9.879 · Cited by 861
Metadata
- Authors
- Sitara, D., Razzaque, M. S., Hesse, M., Yoganathan, S., Taguchi, T., Erben, R. G., J+APw-ppner, H., & Lanske, B.
- Venue
- Matrix Biology
- Publisher
- Elsevier BV
- Published
- 2004-11
- Volume
- 23
- Issue
- 7
- Pages
- 421-432
- ISSN
- 0945-053X (ISSN-L)
- OpenAlex
- W2114372930
- Cited by
- 542
- References
- 63
- FWCI
- 16.95
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.